The congenital intrahepatic arterioportal fistula syndrome: elucidation and proposed classification

Seamus P Norton1, Kevan Jacobson, Stanley P Moroz

  • 1Department of Pediatrics, British Columbia's Children's Hospital, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Insights

Congenital intrahepatic arterioportal fistula, a rare cause of portal hypertension, can be successfully treated with transarterial embolization. Early diagnosis in infants is key for effective radiological management and improved outcomes.

Area of Science:

  • Pediatric Surgery
  • Vascular Anomalies
  • Interventional Radiology

Background:

  • Congenital intrahepatic arterioportal fistula (CHIAPF) is a rare vascular anomaly.
  • CHIAPF can lead to significant complications, including portal hypertension, failure to thrive, and gastrointestinal bleeding.
  • Early diagnosis and intervention are crucial for favorable outcomes.

Observation:

  • This report details a case of an infant with severe failure to thrive, melena, and splenomegaly attributed to CHIAPF.
  • The infant underwent successful treatment via superselective transarterial embolization after multiple attempts.
  • A review of congenital cases was conducted to identify key clinical features.

Findings:

  • Congenital intrahepatic arterioportal fistula is a treatable cause of pediatric portal hypertension.
  • Superselective transarterial embolization can effectively ablate intrahepatic arterioportal fistulas.
  • A proposed classification system aids in guiding treatment decisions for CHIAPF.

Implications:

  • Early recognition of CHIAPF in infants is vital for timely radiological management.
  • Successful embolization offers a curative option for this rare condition.
  • The proposed classification system may standardize treatment approaches for congenital intrahepatic arterioportal fistulas.

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...